PATENT CLAIM ANALYSIS

Application Number: 16199905
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "114000"]

Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.

Claim (Index 8):
A method of treating a long chronic disease in a patient in need of such treatment, the method comprising initiating treatment with the S1P receptor modulator or agonist at a daily dosage which is lower than the standard daily therapeutic dosage during an initial period of treatment and thereafter commencing the administration of the S1P receptor modulator or agonist at the required standard daily therapeutic dosage.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 98.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12655049', '14732013', '14322722', '15986992', '15534929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7546148556897753
- 35 USC 102 Novelty (BERT): 0.5491473151884212
- Combined Prediction Score: 0.7340681016396399
- Mean Citation Score: 288.4315200000001
- Max Citation Score: 407.60342
- Similarity Product: 354.64243075808054

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test